117 related articles for article (PubMed ID: 24793917)
21. Cervical distribution of iodine 131 following total thyroidectomy for thyroid cancer.
Fratkin MJ; Newsome HH; Sharpe AR; Tatum JL
Arch Surg; 1983 Jul; 118(7):864-7. PubMed ID: 6860136
[TBL] [Abstract][Full Text] [Related]
22. Association between residual thyroid carcinoma and diffuse hepatic uptake of 131I following radioiodine ablation in postoperative total thyroidectomy patients.
Tatar FA; Morita E; Ituarte PH; Cavalieri RR; Duh QY; Price DC; Siperstein AE; Clark OH
World J Surg; 2001 Jun; 25(6):718-22. PubMed ID: 11376405
[TBL] [Abstract][Full Text] [Related]
23. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
24. Effective half life of iodine for five thyroidectomy patients using an in vivo gamma camera approach.
Chen CY; Chang PJ; Changlai SP; Pan LK
J Radiat Res; 2007 Nov; 48(6):485-93. PubMed ID: 17971626
[TBL] [Abstract][Full Text] [Related]
25. Postablative 131I SPECT/CT Is Much More Sensitive Than Cervical Ultrasonography for the Detection of Thyroid Remnants in Patients After Total Thyroidectomy for Differentiated Thyroid Cancer.
Bulzacka I; Makarewicz J
Clin Nucl Med; 2020 Dec; 45(12):948-953. PubMed ID: 32969911
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma.
Salvatori M; Raffaelli M; Castaldi P; Treglia G; Rufini V; Perotti G; Lombardi CP; Rubello D; Ardito G; Bellantone R
Eur J Surg Oncol; 2007 Jun; 33(5):648-54. PubMed ID: 17433606
[TBL] [Abstract][Full Text] [Related]
27. The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis.
Hu G; Zhu W; Yang W; Wang H; Shen L; Zhang H
World J Surg; 2016 Jan; 40(1):100-9. PubMed ID: 26578322
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer.
Caglar M; Bozkurt FM; Akca CK; Vargol SE; Bayraktar M; Ugur O; Karaağaoğlu E
Nucl Med Commun; 2012 Mar; 33(3):268-74. PubMed ID: 22205241
[TBL] [Abstract][Full Text] [Related]
29. Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review.
Blumhardt R; Wolin EA; Phillips WT; Salman UA; Walker RC; Stack BC; Metter D
Endocr Relat Cancer; 2014; 21(6):R473-84. PubMed ID: 25277792
[TBL] [Abstract][Full Text] [Related]
30. Determination of remnant thyroid volume: comparison of ultrasonography, radioactive iodine uptake and serum thyroid-stimulating hormone level.
Erbil Y; Barbaros U; Salmaslioglu A; Issever H; Tukenmez M; Adalet I; Bozbora A; Ozarmagan S; Tezelman S
J Laryngol Otol; 2008 Jun; 122(6):615-22. PubMed ID: 17605833
[TBL] [Abstract][Full Text] [Related]
31. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
[TBL] [Abstract][Full Text] [Related]
32. Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation.
Lin JD; Chao TC; Huang MJ; Weng HF; Tzen KY
Am J Clin Oncol; 1998 Feb; 21(1):77-81. PubMed ID: 9499265
[TBL] [Abstract][Full Text] [Related]
33. Postoperative radioactive iodine evaluation of total thyroidectomy for thyroid carcinoma: reappraisal and therapeutic implications.
Attie JN; Bock G; Moskowitz GW; Margouleff D; Dubner S
Head Neck; 1992; 14(4):297-302. PubMed ID: 1517080
[TBL] [Abstract][Full Text] [Related]
34. Iodine Uptake Patterns on Post-ablation Whole Body Scans are Related to Elevated Serum Thyroglobulin Levels After Radioactive Iodine Therapy in Patients with Papillary Thyroid Carcinoma.
Jeong GC; Song M; Park HJ; Min JJ; Bom HS; Cho SG; Park KS; Kang SR; Kim J; Song HC; Kwon SY
Nucl Med Mol Imaging; 2016 Dec; 50(4):329-336. PubMed ID: 27994688
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of total thyroidectomy in the treatment of thyroid carcinoma: postoperative radioactive iodine evaluation of 140 cases.
Attie JN; Moskowitz GW; Margouleff D; Levy LM
Am J Surg; 1979 Oct; 138(4):555-60. PubMed ID: 484783
[TBL] [Abstract][Full Text] [Related]
36. Negative remnant
Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
[TBL] [Abstract][Full Text] [Related]
37. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
38. Controversial ectopic thyroid: a case report of thyroid tissue in the axilla and benign total thyroidectomy.
Kuffner HA; McCook BM; Swaminatha R; Myers EN; Hunt JL
Thyroid; 2005 Sep; 15(9):1095-7. PubMed ID: 16187921
[TBL] [Abstract][Full Text] [Related]
39. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
40. Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer.
Sun Y; Gong J; Guo B; Shang J; Cheng Y; Xu H
Oral Oncol; 2018 Dec; 87():152-157. PubMed ID: 30527231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
